Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
44.3M
-
Shares change
-
+3.54M
-
Total reported value, excl. options
-
$2.81B
-
Value change
-
+$189M
-
Put/Call ratio
-
0.51
-
Number of buys
-
104
-
Number of sells
-
-73
-
Price
-
$63.48
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q2 2018
222 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q2 2018.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.3M shares
of 62.5M outstanding shares and own 70.91% of the company stock.
Largest 10 shareholders include FMR LLC (6.58M shares), VANGUARD GROUP INC (3.62M shares), BlackRock Inc. (3.32M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.12M shares), WELLINGTON MANAGEMENT GROUP LLP (2.7M shares), STATE STREET CORP (1.85M shares), OppenheimerFunds, Inc. (1.68M shares), Hillhouse Capital Management, Ltd. (1.43M shares), TimesSquare Capital Management, LLC (1.07M shares), and PERCEPTIVE ADVISORS LLC (961K shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.